Know thyself: NK-cell inhibitory receptors prompt self-tolerance, education, and viral control

Frontiers in Immunology

Volumn 5, Issue APR, 2014, Pages

  Nash, William T ^a   Teoh, Jeffrey ^a   Wei, Hairong ^a   Gamache, Awndre ^a   Brown, Michael G ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Education; Immunity; Inhibitory receptors; Licensing; NK cells; Virus control

Indexed keywords

INHIBITORY NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR; UNCLASSIFIED DRUG;

DNA POLYMORPHISM; EVOLUTION; GENE EXPRESSION; HUMAN; IMMUNE EVASION; IMMUNITY; IMMUNOLOGICAL TOLERANCE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR MIMICRY; MUTATION; NATURAL KILLER CELL; REVIEW; VIRUS INFECTION;

EID: 84900875435     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00175     Document Type: Review

References (168)

1. Herberman RB, Nunn ME, Lavrin DH. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer (1975) 16:216-29. doi:10.1002/ijc.2910160205.
2. Kärre K. Natural killer cell recognition of missing self. Nat Immunol (2008) 9:477-80. doi:10.1038/ni0508-477.
3. Orange JS. Unraveling human natural killer cell deficiency. J Clin Invest (2012) 122:798-801. doi:10.1172/JCI62620.
4. Orange JS. Natural killer cell deficiency. J Allergy Clin Immunol (2013) 132:515-25. doi:10.1016/j.jaci.2013.07.020.
5. Martin AM, Kulski JK, Witt C, Pontarotti P, Christiansen FT. Leukocyte Ig-like receptor complex (LRC) in mice and men. Trends Immunol (2002) 23:81-8. doi:10.1016/S1471-4906(01)02155-X.
6. Yokoyama WM, Plougastel BFM. Immune functions encoded by the natural killer gene complex. Nat Rev Immunol (2003) 3:304-16. doi:10.1038/nri1055.
7. Kelley J, Walter L, Trowsdale J. Comparative genomics of natural killer cell receptor gene clusters. PLoS Genet (2005) 1:129-39. doi:10.1371/journal.pgen.0010027.
8. Carlyle JR, Mesci A, Fine JH, Chen P, Bélanger S, Tai LH, et al. Evolution of the Ly49 and Nkrp1 recognition systems. Semin Immunol (2008) 20:321-30. doi:10.1016/j.smim.2008.05.004.
9. Yoder JA, Litman GW. The phylogenetic origins of natural killer receptors and recognition: relationships, possibilities, and realities. Immunogenetics (2011) 63:123-41. doi:10.1007/s00251-010-0506-4.
10. Parham P, Moffett A. Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution. Nat Rev Immunol (2013) 13:133-44. doi:10.1038/nri3370.
11. Moussa P, Marton J, Vidal SM, Fodil-Cornu N. Genetic dissection of NK cell responses. Front Immunol (2013) 3:425. doi:10.3389/fimmu.2012.00425.
12. Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, et al. Innate or adaptive immunity? The example of natural killer cells. Science (2011) 331:44-9. doi:10.1126/science.1198687.
13. Lanier LL. NK cell recognition. Annu Rev Immunol (2005) 23:225-74. doi:10.1146/annurev.immunol.23.021704.115526.
14. Raulet DH, Gasser S, Gowen BG, Deng W, Jung H. Regulation of ligands for the NKG2D activating receptor. Annu Rev Immunol (2013) 31:413-41. doi:10.1146/annurev-immunol-032712-095951.
15. Koch J, Steinle A, Watzl C, Mandelboim O. Activating natural cytotoxicity receptors of natural killer cells in cancer and infection. Trends Immunol (2013) 34:182-91. doi:10.1016/j.it.2013.01.003.
16. Jost S, Altfeld M. Control of human viral infections by natural killer cells. Annu Rev Immunol (2013) 31:163-94. doi:10.1146/annurev-immunol-032712-100001.
17. Long EO, Sik Kim H, Liu D, Peterson ME, Rajagopalan S. Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol (2013) 31:227-58. doi:10.1146/annurev-immunol-020711-075005.
18. Zimmer J, Donato L, Hanau D, Cazenave JP, Tongio MM, Moretta A, et al. Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome). J Exp Med (1998) 187:117-22. doi:10.1084/jem.187.1.117.
19. Gadola SD, Moins-Teisserenc HT, Trowsdale J, Gross WL, Cerundolo V. TAP deficiency syndrome. Clin Exp Immunol (2000) 121:173-8. doi:10.1046/j.1365-2249.2000.01264.x.
20. Arkwright PD, Abinun M, Cant AJ. Autoimmunity in human primary immunodeficiency diseases. Blood (2002) 99:2694-702. doi:10.1182/blood.V99.8.2694.
21. Zimmer J, Andrès E, Donato L, Hanau D, Hentges F, de la Salle H. Clinical and immunological aspects of HLA class I deficiency. QJM (2005) 98:719-27. doi:10.1093/qjmed/hci112.
22. Villa-Forte A, de la Salle H, Fricker D, Hentges F, Zimmer J. HLA class I deficiency syndrome mimicking Wegener's granulomatosis. Arthritis Rheum (2008) 58:2579-82. doi:10.1002/art.23675.
23. Caversaccio M, Bonél H, Carter R, Williams A, Gadola S. TAP deficiency syndrome: chronic rhinosinusitis and conductive hearing loss. Eur Arch Otorhinolaryngol (2008) 265:1289-92. doi:10.1007/s00405-008-0610-3.
24. Bashirova AA, Martin MP, McVicar DW, Carrington M. The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. Annu Rev Genomics Hum Genet (2006) 7:277-300. doi:10.1146/annurev.genom.7.080505.115726.
25. Joncker NT, Raulet DH. Regulation of NK cell responsiveness to achieve self-tolerance and maximal responses to diseased target cells. Immunol Rev (2008) 224:85-97. doi:10.1111/j.1600-065X.2008.00658.x.
26. Elliott JM, Yokoyama WM. Unifying concepts of MHC-dependent natural killer cell education. Trends Immunol (2011) 32:364-72. doi:10.1016/j.it.2011.06.001.
27. Lowin-Kropf B, Held W. Positive impact of inhibitory Ly49 receptor-MHC class I interaction on NK cell development. J Immunol (2000) 165:91-5.
28. Fernandez NC, Treiner E, Vance RE, Jamieson AM, Lemieux S, Raulet DH. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood (2005) 105:4416-23. doi:10.1182/blood-2004-08-3156.
29. Kim S, Poursine-Laurent J, Truscott SM, Lybarger L, Song YJ, Yang L, et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature (2005) 436:709-13. doi:10.1038/nature03847.
30. Held W. Tolerance and reactivity of NK cells: two sides of the same coin? Eur J Immunol (2008) 38:2930-3. doi:10.1002/eji.200838755.
31. Raulet DH, Vance RE. Self-tolerance of natural killer cells. Nat Rev Immunol (2006) 6:520-31. doi:10.1038/nri1863.
32. Ljunggren HG, Kärre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today (1990) 11:237-44. doi:10.1016/1471-4906(90)90097-H.
33. Raulet DH. Missing self recognition and self tolerance of natural killer (NK) cells. Semin Immunol (2006) 18:145-50. doi:10.1016/j.smim.2006.03.003.
34. Brodin P, Kärre K, Höglund P. NK cell education: not an on-off switch but a tunable rheostat. Trends Immunol (2009) 30:143-9. doi:10.1016/j.it.2009.01.006.
35. Brodin P, Lakshmikanth T, Johansson S, Kärre K, Höglund P. The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells. Blood (2009) 113:2434-41. doi:10.1182/blood-2008-05-156836.
36. Joncker NT, Fernandez NC, Treiner E, Vivier E, Raulet DH. NK cell responsiveness is tuned commensurate with the number of inhibitory receptors for self-MHC class I: the rheostat model. J Immunol (2009) 182:4572-80. doi:10.4049/jimmunol.0803900.
37. Elliott JM, Wahle JA, Yokoyama WM. MHC class I-deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I-sufficient environment. J Exp Med (2010) 207:2073-9. doi:10.1084/jem.20100986.
38. Joncker NT, Shifrin N, Delebecque F, Raulet DH. Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment. J Exp Med (2010) 207:2065-72. doi:10.1084/jem.20100570.
39. Ebihara T, Jonsson AH, Yokoyama WM. Natural killer cell licensing in mice with inducible expression of MHC class I. Proc Natl Acad Sci U S A (2013) 110:E4232-7. doi:10.1073/pnas.1318255110.
40. Lanier LL. Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol (2008) 9:495-502. doi:10.1038/ni1581.
41. Campbell KS, Purdy AK. Structure/function of human killer cell immunoglobulin-like receptors: lessons from polymorphisms, evolution, crystal structures and mutations. Immunology (2011) 132:315-25. doi:10.1111/j.1365-2567.2010.03398.x.
42. Yokoyama WM, Kim S. Licensing of natural killer cells by self-major histocompatibility complex class I. Immunol Rev (2006) 214:143-54. doi:10.1111/j.1600-065X.2006.00458.x.
43. Wang JW, Howson JM, Ghansah T, Desponts C, Ninos JM, May SL, et al. Influence of SHIP on the NK repertoire and allogeneic bone marrow transplantation. Science (2002) 295:2094-7. doi:10.1126/science.1068438.
44. Fortenbery NR, Paraiso KHT, Taniguchi M, Brooks C, Ibrahim L, Kerr WG. SHIP influences signals from CD48 and MHC class I ligands that regulate NK cell homeostasis, effector function, and repertoire formation. J Immunol (2010) 184:5065-74. doi:10.4049/jimmunol.0901862.
45. Lowin-Kropf B, Kunz B, Beermann F, Held W. Impaired natural killing of MHC class I-deficient targets by NK cells expressing a catalytically inactive form of SHP-1. J Immunol (2000) 165:1314-21.
46. Peterson ME, Long EO. Inhibitory receptor signaling via tyrosine phosphorylation of the adaptor Crk. Immunity (2008) 29:578-88. doi:10.1016/j.immuni.2008.07.014.
47. Liu D, Peterson ME, Long EO. The adaptor protein Crk controls activation and inhibition of natural killer cells. Immunity (2012) 36:600-11. doi:10.1016/j.immuni.2012.03.007.
48. Thomas LM, Peterson ME, Long EO. Cutting edge: NK cell licensing modulates adhesion to target cells. J Immunol (2013) 191:3981-5. doi:10.4049/jimmunol.1301159.
49. Matsumoto G, Nghiem MP, Nozaki N, Schmits R, Penninger JM. Cooperation between CD44 and LFA-1/CD11a adhesion receptors in lymphokine-activated killer cell cytotoxicity. J Immunol (1998) 160:5781-9.
50. Matsumoto G, Omi Y, Lee U, Nishimura T, Shindo J, Penninger JM. Adhesion mediated by LFA-1 is required for efficient IL-12-induced NK and NKT cell cytotoxicity. Eur J Immunol (2000) 30:3723-31. doi:10.1002/1521-4141(200012)30:12<3723::AID-IMMU3723>3.0.CO;2-9.
51. Bryceson YT, March ME, Barber DF, Ljunggren HG, Long EO. Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells. J Exp Med (2005) 202:1001-12. doi:10.1084/jem.20051143.
52. Hogg N, Leitinger B. Shape and shift changes related to the function of leukocyte integrins LFA-1 and Mac-1. J Leukoc Biol (2001) 69:893-8.
53. Orange JS, Fassett MS, Koopman LA, Boyson JE, Strominger JL. Viral evasion of natural killer cells. Nat Immunol (2002) 3:1006-12. doi:10.1038/ni1102-1006.
54. Jonjic S, Babic M, Polic B, Krmpotic A. Immune evasion of natural killer cells by viruses. Curr Opin Immunol (2008) 20:30-8. doi:10.1016/j.coi.2007.11.002.
55. Jones TR, Wiertz EJ, Sun L, Fish KN, Nelson JA, Ploegh HL. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc Natl Acad Sci U S A (1996) 93:11327-33. doi:10.1073/pnas.93.21.11327.
56. Park B, Kim Y, Shin J, Lee S, Cho K, Früh K, et al. Human cytomegalovirus inhibits tapasin-dependent peptide loading and optimization of the MHC class I peptide cargo for immune evasion. Immunity (2004) 20:71-85. doi:10.1016/S1074-7613(03)00355-8.
57. Noriega VM, Hesse J, Gardner TJ, Besold K, Plachter B, Tortorella D. Human cytomegalovirus US3 modulates destruction of MHC class I molecules. Mol Immunol (2012) 51:245-53. doi:10.1016/j.molimm.2012.03.024.
58. Lehner PJ, Karttunen JT, Wilkinson GW, Cresswell P. The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. Proc Natl Acad Sci U S A (1997) 94:6904-9. doi:10.1073/pnas.94.13.6904.
59. Llano M, Gumá M, Ortega M, Angulo A, López-Botet M. Differential effects of US2, US6 and US11 human cytomegalovirus proteins on HLA class Ia and HLA-E expression: impact on target susceptibility to NK cell subsets. Eur J Immunol (2003) 33:2744-54. doi:10.1002/eji.200324182.
60. Gewurz BE, Wang EW, Tortorella D, Schust DJ, Ploegh HL. Human cytomegalovirus US2 endoplasmic reticulum-lumenal domain dictates association with major histocompatibility complex class I in a locus-specific manner. J Virol (2001) 75:5197-204. doi:10.1128/JVI.75.11.5197-5204.2001.
61. Schust DJ, Tortorella D, Seebach J, Phan C, Ploegh HL. Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11. J Exp Med (1998) 188:497-503. doi:10.1084/jem.188.3.497.
62. Machold RP, Wiertz EJ, Jones TR, Ploegh HL. The HCMV gene products US11 and US2 differ in their ability to attack allelic forms of murine major histocompatibility complex (MHC) class I heavy chains. J Exp Med (1997) 185:363-6. doi:10.1084/jem.185.2.363.
63. Schaefer MR, Wonderlich ER, Roeth JF, Leonard JA, Collins KL. HIV-1 Nef targets MHC-I and CD4 for degradation via a final common beta-COP-dependent pathway in T cells. PLoS Pathog (2008) 4:e1000131. doi:10.1371/journal.ppat.1000131.
64. Le Gall S, Erdtmann L, Benichou S, Berlioz-Torrent C, Liu L, Benarous R, et al. Nef interacts with the μ subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. Immunity (1998) 8:483-95. doi:10.1016/S1074-7613(00)80553-1.
65. Collins KL, Chen BK, Kalams SA, Walker BD, Baltimore D. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature (1998) 391:397-401. doi:10.1038/34929.
66. Cohen GB, Gandhi RT, Davis DM, Mandelboim O, Chen BK, Strominger JL, et al. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity (1999) 10:661-71. doi:10.1016/S1074-7613(00)80065-5.
67. Flores-Villanueva PO, Yunis EJ, Delgado JC, Vittinghoff E, Buchbinder S, Leung JY, et al. Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity. Proc Natl Acad Sci U S A (2001) 98:5140-5. doi:10.1073/pnas.071548198.
68. Martin MP, Qi Y, Gao X, Yamada E, Nolte MA, Pereyra F, et al. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet (2007) 39:733-40. doi:10.1038/ng2035.
69. Tomescu C, Duh FM, Hoh R, Viviani A, Harvill K, Martin MP, et al. Impact of protective killer inhibitory receptor/human leukocyte antigen genotypes on natural killer cell and T-cell function in HIV-1-infected controllers. AIDS (2012) 26:1869-78. doi:10.1097/QAD.0b013e32835861b0.
70. Rajapaksa US, Li D, Peng YC, McMichael AJ, Dong T, Xu XN. HLA-B may be more protective against HIV-1 than HLA-A because it resists negative regulatory factor (Nef) mediated down-regulation. Proc Natl Acad Sci U S A (2012) 109:13353-8. doi:10.1073/pnas.1204199109.
71. Dasgupta A, Hammarlund E, Slifka MK, Früh K. Cowpox virus evades CTL recognition and inhibits the intracellular transport of MHC class I molecules. J Immunol (2007) 178:1654-61.
72. Byun M, Wang X, Pak M, Hansen TH, Yokoyama WM. Cowpox virus exploits the endoplasmic reticulum retention pathway to inhibit MHC class I transport to the cell surface. Cell Host Microbe (2007) 2:306-15. doi:10.1016/j.chom.2007.09.002.
73. Alzhanova D, Edwards DM, Hammarlund E, Scholz IG, Horst D, Wagner MJ, et al. Cowpox virus inhibits the transporter associated with antigen processing to evade T cell recognition. Cell Host Microbe (2009) 6:433-45. doi:10.1016/j.chom.2009.09.013.
74. McCoy WH IV, Wang X, Yokoyama WM, Hansen TH, Fremont DH. Cowpox virus employs a two-pronged strategy to outflank MHCI antigen presentation. Mol Immunol (2013) 55:156-8. doi:10.1016/j.molimm.2012.11.011.
75. Tomasec P, Braud VM, Rickards C, Powell MB, McSharry BP, Gadola S, et al. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science (2000) 287:1031-3. doi:10.1126/science.287.5455.1031.
76. Ulbrecht M, Martinozzi S, Grzeschik M, Hengel H, Ellwart JW, Pla M, et al. Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis. J Immunol (2000) 164:5019-22.
77. Heatley SL, Pietra G, Lin J, Widjaja JM, Harpur CM, Lester S, et al. Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells. J Biol Chem (2013) 288:8679-90. doi:10.1074/jbc.M112.409672.
78. Ziegler H, Thäle R, Lucin P, Muranyi W, Flohr T, Hengel H, et al. A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. Immunity (1997) 6:57-66. doi:10.1016/S1074-7613(00)80242-3.
79. Reusch U, Muranyi W, Lucin P, Burgert HG, Hengel H, Koszinowski UH. A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation. EMBO J (1999) 18:1081-91. doi:10.1093/emboj/18.4.1081.
80. Kleijnen MF, Huppa JB, Lucin P, Mukherjee S, Farrell H, Campbell AE, et al. A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface. EMBO J (1997) 16:685-94. doi:10.1093/emboj/16.4.685.
81. Kavanagh DG, Gold MC, Wagner M, Koszinowski UH, Hill AB. The multiple immune-evasion genes of murine cytomegalovirus are not redundant: m4 and m152 inhibit antigen presentation in a complementary and cooperative fashion. J Exp Med (2001) 194:967-78. doi:10.1084/jem.194.7.967.
82. Xie X, Dighe A, Clark P, Sabastian P, Buss S, Brown MG. Deficient major histocompatibility complex-linked innate murine cytomegalovirus immunity in MA/My.L-H2b mice and viral downregulation of H-2k class I proteins. J Virol (2007) 81:229-36. doi:10.1128/JVI.00997-06.
83. Wagner M, Gutermann A, Podlech J, Reddehase MJ, Koszinowski UH. Major histocompatibility complex class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus. J Exp Med (2002) 196:805-16. doi:10.1084/jem.20020811.
84. Pinto AK, Munks MW, Koszinowski UH, Hill AB. Coordinated function of murine cytomegalovirus genes completely inhibits CTL lysis. J Immunol (2006) 177:3225-34.
85. Babic M, Pyzik M, Zafirova B, Mitrovic M, Butorac V, Lanier LL, et al. Cytomegalovirus immunoevasin reveals the physiological role of "missing self" recognition in natural killer cell dependent virus control in vivo. J Exp Med (2010) 207:2663-73. doi:10.1084/jem.20100921.
86. Corbett AJ, Forbes CA, Moro D, Scalzo AA. Extensive sequence variation exists among isolates of murine cytomegalovirus within members of the m02 family of genes. J Gen Virol (2007) 88:758-69. doi:10.1099/vir.0.82623-0.
87. Cheng TP, Valentine MC, Gao J, Pingel JT, Yokoyama WM. Stability of murine cytomegalovirus genome after in vitro and in vivo passage. J Virol (2010) 84:2623-8. doi:10.1128/JVI.02142-09.
88. Cullen BR. MicroRNAs as mediators of viral evasion of the immune system. Nat Immunol (2013) 14:205-10. doi:10.1038/ni.2537.
89. Elias S, Mandelboim O. Battle of the midgets: innate microRNA networking. RNA Biol (2012) 9:792-8. doi:10.4161/rna.19717.
90. Stern-Ginossar N, Elefant N, Zimmermann A, Wolf DG, Saleh N, Biton M, et al. Host immune system gene targeting by a viral miRNA. Science (2007) 20:376-81. doi:10.1126/science.1140956.
91. Nachmani D, Stern-Ginossar N, Sarid R, Mandelboim O. Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Cell Host Microbe (2009) 5:376-85. doi:10.1016/j.chom.2009.03.003.
92. Prod'homme V, Griffin C, Aicheler RJ, Wang EC, McSharry BP, Rickards CR, et al. The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1- NK cells. J Immunol (2007) 178:4473-81.
93. Campbell JA, Trossman DS, Yokoyama WM, Carayannopoulos LN. Zoonotic orthopoxviruses encode a high-affinity antagonist of NKG2D. J Exp Med (2007) 204:1311-7. doi:10.1084/jem.20062026.
94. Cretney E, Degli-Esposti MA, Densley EH, Farrell HE, Davis-Poynter NJ, Smyth MJ. m144, a murine cytomegalovirus (MCMV)-encoded major histocompatibility complex class I homologue, confers tumor resistance to natural killer cell-mediated rejection. J Exp Med (1999) 190:435-44. doi:10.1084/jem.190.3.435.
95. Kubota A, Kubota S, Farrell HE, Davis-Poynter N, Takei F. Inhibition of NK cells by murine CMV-encoded class I MHC homologue m144. Cell Immunol (1999) 191:145-51. doi:10.1006/cimm.1998.1424.
96. Natarajan K, Hicks A, Mans J, Robinson H, Guan R, Mariuzza RA, et al. Crystal structure of the murine cytomegalovirus MHC-I homolog m144. J Mol Biol (2006) 358:157-71. doi:10.1016/j.jmb.2006.01.068.
97. Farrell HE, Vally H, Lynch DM, Fleming P, Shellam GR, Scalzo AA, et al. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature (1997) 386:510-4. doi:10.1038/386510a0.
98. Smith HR, Heusel JW, Mehta IK, Kim S, Dorner BG, Naidenko OV, et al. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci U S A (2002) 99:8826-31. doi:10.1073/pnas.092258599.
99. Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science (2002) 296:1323-6. doi:10.1126/science.1070884.
100. Corbett AJ, Coudert JD, Forbes CA, Scalzo AA. Functional consequences of natural sequence variation of murine cytomegalovirus m157 for Ly49 receptor specificity and NK cell activation. J Immunol (2011) 186:1713-22. doi:10.4049/jimmunol.1003308.
101. Adams EJ, Juo ZS, Venook RT, Boulanger MJ, Arase H, Lanier LL, et al. Structural elucidation of the m157 mouse cytomegalovirus ligand for Ly49 natural killer cell receptors. Proc Natl Acad Sci U S A (2007) 104:10128-33. doi:10.1073/pnas.0703735104.
102. Berry R, Ng N, Saunders PM, Vivian JP, Lin J, Deuss FA, et al. Targeting of a natural killer cell receptor family by a viral immunoevasin. Nat Immunol (2013) 14:699-705. doi:10.1038/ni.2605.
103. Bubic I, Wagner M, Krmpotic A, Saulig T, Kim S, Yokoyama WM, et al. Gain of virulence caused by loss of a gene in murine cytomegalovirus. J Virol (2004) 78:7536-44. doi:10.1128/JVI.78.14.7536-7544.2004.
104. Brown MG, Dokun AO, Heusel JW, Smith HR, Beckman DL, Blattenberger EA, et al. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science (2001) 292:934-7. doi:10.1126/science.1060042.
105. Daniels KA, Devora G, Lai WC, O'Donnell CL, Bennett M, Welsh RM. Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J Exp Med (2001) 194:29-44. doi:10.1084/jem.194.1.29.
106. Lee SH, Girard S, Macina D, Busà M, Zafer A, Belouchi A, et al. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat Genet (2001) 28:42-5. doi:10.1038/ng0501-42.
107. Makrigiannis AP, Pau AT, Saleh A, Winkler-Pickett R, Ortaldo JR, Anderson SK. Class I MHC-binding characteristics of the 129/J Ly49 repertoire. J Immunol (2001) 166:5034-43.
108. Lanier LL. Evolutionary struggles between NK cells and viruses. Nat Rev Immunol (2008) 8:259-68. doi:10.1038/nri2276.
109. Miletic A, Krmpotic A, Jonjic S. The evolutionary arms race between NK cells and viruses: who gets the short end of the stick? Eur J Immunol (2013) 43:867-77. doi:10.1002/eji.201243101.
110. Sun JC, Lanier LL. The natural selection of herpesviruses and virus-specific NK cell receptors. Viruses (2009) 1:362-82. doi:10.3390/v1030362.
111. Carrillo-Bustamante P, Kesmir C, de Boer RJ. Virus encoded MHC-like decoys diversify the inhibitory KIR repertoire. PLoS Comput Biol (2013) 9:e1003264. doi:10.1371/journal.pcbi.1003264.
112. Mandelboim O, Lieberman N, Lev M, Paul L, Arnon TI, Bushkin Y, et al. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature (2001) 409:1055-60. doi:10.1038/35059110.
113. Kielczewska A, Pyzik M, Sun T, Krmpotic A, Lodoen MB, Munks MW, et al. Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 correlates with the NK cell antiviral response. J Exp Med (2009) 206:515-23. doi:10.1084/jem.20080954.
114. Jarahian M, Fiedler M, Cohnen A, Djandji D, Hämmerling GJ, Gati C, et al. Modulation of NKp30- and NKp46-mediated natural killer cell responses by poxviral hemagglutinin. PLoS Pathog (2011) 7:e1002195. doi:10.1371/journal.ppat.1002195.
115. Magri G, Muntasell A, Romo N, Sáez-Borderías A, Pende D, Geraghty DE, et al. NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies. Blood (2011) 117:848-56. doi:10.1182/blood-2010-08-301374.
116. Chaigne-Delalande B, Li FY, O'Connor GM, Lukacs MJ, Jiang P, Zheng L, et al. Mg2+ regulates cytotoxic functions of NK and CD8 T cells in chronic EBV infection through NKG2D. Science (2013) 341:186-91. doi:10.1126/science.1240094.
117. Gumá M, Angulo A, Vilches C, Gómez-Lozano N, Malats N, López-Botet M. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood (2004) 104:3664-71. doi:10.1182/blood-2004-05-2058.
118. Tay CH, Yu LY, Kumar V, Mason L, Ortaldo JR, Welsh RM. The role of LY49 NK cell subsets in the regulation of murine cytomegalovirus infections. J Immunol (1999) 162:718-26.
119. Makrigiannis AP, Rousselle E, Anderson SK. Independent control of Ly49g alleles: implications for NK cell repertoire selection and tumor cell killing. J Immunol (2004) 172:1414-25.
120. Barao I, Alvarez M, Ames E, Orr MT, Stefanski HE, Blazar BR, et al. Mouse Ly49G2+ NK cells dominate early responses during both immune reconstitution and activation independently of MHC. Blood (2011) 117:7032-41. doi:10.1182/blood-2010-11-316653.
121. Barao I, Wright PW, Sungur CM, Anderson SK, Redelman D, Murphy WJ. Differential expression of the Ly49GB6, but not the Ly49G(BALB), receptor isoform during natural killer cell reconstitution after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2013) 19:1446-52. doi:10.1016/j.bbmt.2013.07.021.
122. Xie X, Stadnisky MD, Brown MG. MHC class I D(k) locus and Ly49G2+ NK cells confer H-2k resistance to murine cytomegalovirus. J Immunol (2009) 182:7163-71. doi:10.4049/jimmunol.0803933.
123. Xie X, Stadnisky MD, Coats ER, Ahmed Rahim MM, Lundgren A, Xu W, et al. MHC class I D(k) expression in hematopoietic and nonhematopoietic cells confers natural killer cell resistance to murine cytomegalovirus. Proc Natl Acad Sci U S A (2010) 107:8754-9. doi:10.1073/pnas.0913126107.
124. Prince J, Lundgren A, Stadnisky MD, Nash WT, Beeber A, Turner SD, et al. Multiparametric analysis of host response to murine cytomegalovirus in MHC class I-disparate mice reveals primacy of D(k)-licensed Ly49G2+ NK cells in viral control. J Immunol (2013) 191:4709-19. doi:10.4049/jimmunol.1301388.
125. Mela CM, Burton CT, Imami N, Nelson M, Steel A, Gazzard BG, et al. Switch from inhibitory to activating NKG2 receptor expression in HIV-1 infection: lack of reversion with highly active antiretroviral therapy. AIDS (2005) 19:1761-9. doi:10.1097/01.aids.0000183632.12418.33.
126. Gumá M, Cabrera C, Erkizia I, Bofill M, Clotet B, Ruiz L, et al. Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients. J Infect Dis (2006) 194:38-41. doi:10.1086/504719.
127. Lopez-Vergès S, Milush JM, Schwartz BS, Pando MJ, Jarjoura J, York VA, et al. Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc Natl Acad Sci U S A (2011) 108:14725-32. doi:10.1073/pnas.1110900108.
128. Foley B, Cooley S, Verneris MR, Pitt M, Curtsinger J, Luo X, et al. Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function. Blood (2012) 119:2665-74. doi:10.1182/blood-2011-10-386995.
129. Béziat V, Liu LL, Malmberg JA, Ivarsson MA, Sohlberg E, Björklund AT, et al. NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs. Blood (2013) 121:2678-88. doi:10.1182/blood-2012-10-459545.
130. Charoudeh HN, Terszowski G, Czaja K, Gonzalez A, Schmitter K, Stern M. Modulation of the natural killer cell KIR repertoire by cytomegalovirus infection. Eur J Immunol (2013) 43:480-7. doi:10.1002/eji.201242389.
131. Muntasell A, Vilches C, Angulo A, López-Botet M. Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: a different perspective of the host-pathogen interaction. Eur J Immunol (2013) 43:1133-41. doi:10.1002/eji.201243117.
132. Björkström NK, Lindgren T, Stoltz M, Fauriat C, Braun M, Evander M, et al. Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J Exp Med (2011) 208:13-21. doi:10.1084/jem.20100762.
133. Petitdemange C, Becquart P, Wauquier N, Béziat V, Debré P, Leroy EM, et al. Unconventional repertoire profile is imprinted during acute chikungunya infection for natural killer cells polarization toward cytotoxicity. PLoS Pathog (2011) 7:e1002268. doi:10.1371/journal.ppat.1002268.
134. Gregson JNS, Kuri-Cervantes L, Mela CM, Gazzard BG, Bower M, Goodier MR. Short communication: NKG2C +NK cells contribute to increases in CD16+CD56- cells in HIV type 1+ individuals with high plasma viral load. AIDS Res Hum Retroviruses (2013) 29:84-8. doi:10.1089/AID.2011.0397.
135. Béziat V, Dalgard O, Asselah T, Halfon P, Bedossa P, Boudifa A, et al. CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients. Eur J Immunol (2012) 42:447-57. doi:10.1002/eji.201141826.
136. Saghafian-Hedengren S, Sohlberg E, Theorell J, Carvalho-Queiroz C, Nagy N, Persson JO, et al. Epstein-Barr virus coinfection in children boosts cytomegalovirus-induced differentiation of natural killer cells. J Virol (2013) 87:13446-55. doi:10.1128/JVI.02382-13.
137. Alter G, Rihn S, Walter K, Nolting A, Martin M, Rosenberg ES, et al. HLA class I subtype-dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection. J Virol (2009) 83:6798-805. doi:10.1128/JVI.00256-09.
138. Pelak K, Need AC, Fellay J, Shianna KV, Feng S, Urban TJ, et al. Copy number variation of KIR genes influences HIV-1 control. PLoS Biol (2011) 9:e1001208. doi:10.1371/journal.pbio.1001208.
139. Brown MG, Scalzo AA. NK gene complex dynamics and selection for NK cell receptors. Semin Immunol (2008) 20:361-8. doi:10.1016/j.smim.2008.06.004.
140. Dokun AO, Kim S, Smith HR, Kang HS, Chu DT, Yokoyama WM. Specific and nonspecific NK cell activation during virus infection. Nat Immunol (2001) 2:951-6. doi:10.1038/ni714.
141. Scalzo AA, Lyons PA, Fitzgerald NA, Forbes CA, Yokoyama WM, Shellam GR. Genetic mapping of Cmv1 in the region of mouse chromosome 6 encoding the NK gene complex-associated loci Ly49 and mus NKR-P1. Gene Ther (1995) 27:435-41. doi:10.1006/geno.1995.1074.
142. Brown M, Scalzo A, Stone L, Clark P, Du Y, Palanca B, et al. Natural killer gene complex (Nkc) allelic variability in inbred mice: evidence for Nkc haplotypes. Immunogenetics (2001) 53:584-91. doi:10.1007/s002510100365.
143. Desrosiers MP, Kielczewska A, Loredo-Osti JC, Adam SG, Makrigiannis AP, Lemieux S, et al. Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell-mediated innate resistance to cytomegalovirus infection. Nat Genet (2005) 37:593-9. doi:10.1038/ng1564.
144. Dighe A, Rodriguez M, Sabastian P, Xie X, McVoy M, Brown MG. Requisite H2k role in NK cell-mediated resistance in acute murine cytomegalovirus-infected MA/My mice. J Immunol (2005) 175:6820-8.
145. Fodil-Cornu N, Loredo-Osti JC, Vidal SM. NK cell receptor/H2-Dk-dependent host resistance to viral infection is quantitatively modulated by H2q inhibitory signals. PLoS Genet (2011) 7:e1001368. doi:10.1371/journal.pgen.1001368.
146. Orr MT, Murphy WJ, Lanier LL. "Unlicensed" natural killer cells dominate the response to cytomegalovirus infection. Nat Immunol (2010) 11:321-7. doi:10.1038/ni.1849.
147. Sungur CM, Tang-Feldman YJ, Ames E, Alvarez M, Chen M, Longo DL, et al. Murine natural killer cell licensing and regulation by T regulatory cells in viral responses. Proc Natl Acad Sci U S A (2013) 110:7401-6. doi:10.1073/pnas.1218767110.
148. Sungur CM, Tang-Feldman YJ, Zamora AE, Alvarez M, Pomeroy C, Murphy WJ. Murine NK-cell licensing is reflective of donor MHC-I following allogeneic hematopoietic stem cell transplantation in murine cytomegalovirus responses. Blood (2013) 122:1518-21. doi:10.1182/blood-2013-02-483503.
149. Wu MF, Raulet DH. Class I-deficient hemopoietic cells and nonhemopoietic cells dominantly induce unresponsiveness of natural killer cells to class I-deficient bone marrow cell grafts. J Immunol (1997) 158:1628-33.
150. Johansson MH, Bieberich C, Jay G, Kärre K, Höglund P. Natural killer cell tolerance in mice with mosaic expression of major histocompatibility complex class I transgene. J Exp Med (1997) 186:353-64. doi:10.1084/jem.186.3.353.
151. Haas P, Loiseau P, Tamouza R, Cayuela JM, Moins-Teisserenc H, Busson M, et al. NK-cell education is shaped by donor HLA genotype after unrelated allogeneic hematopoietic stem cell transplantation. Blood (2011) 117:1021-9. doi:10.1182/blood-2010-02-269381.
152. Brooks CR, Elliott T, Parham P, Khakoo SI. The inhibitory receptor NKG2A determines lysis of vaccinia virus-infected autologous targets by NK cells. J Immunol (2006) 176:1141-7.
153. Jamil KM, Khakoo SI. KIR/HLA interactions and pathogen immunity. J Biomed Biotechnol (2011) 2011:e298348. doi:10.1155/2011/298348.
154. Fadda L, O'Connor GM, Kumar S, Piechocka-Trocha A, Gardiner CM, Carrington M, et al. Common HIV-1 peptide variants mediate differential binding of KIR3DL1 to HLA-Bw4 molecules. J Virol (2011) 85:5970-4. doi:10.1128/JVI.00412-11.
155. Alter G, Altfeld M. NK cells in HIV-1 infection: evidence for their role in the control of HIV-1 infection. J Intern Med (2009) 265:29-42. doi:10.1111/j.1365-2796.2008.02045.x.
156. Thomas R, Apps R, Qi Y, Gao X, Male V, O'hUigin C, et al. HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat Genet (2009) 41:1290-4. doi:10.1038/ng.486.
157. Ballana E, Ruiz-de Andres A, Mothe B, Ramirez de Arellano E, Aguilar F, Badia R, et al. Differential prevalence of the HLA-C-35 CC genotype among viremic long term non-progressor and elite controller HIV+ individuals. Immunity (2012) 217:889-94. doi:10.1016/j.imbio.2011.12.012.
158. Charoudeh H, Schmied L, Gonzalez A, Terszowski G, Czaja K, Schmitter K, et al. Quantity of HLA-C surface expression and licensing of KIR2DL+ natural killer cells. Immunogenetics (2012) 64:739-45. doi:10.1007/s00251-012-0633-1.
159. Apps R, Qi Y, Carlson JM, Chen H, Gao X, Thomas R, et al. Influence of HLA-C expression level on HIV control. Science (2013) 340:87-91. doi:10.1126/science.1232685.
160. Kulkarni S, Qi Y, O'hUigin C, Pereyra F, Ramsuran V, McLaren P, et al. Genetic interplay between HLA-C and MIR148A in HIV control and Crohn disease. Proc Natl Acad Sci U S A (2013) 110:20705-10. doi:10.1073/pnas.1312237110.
161. Alter G, Heckerman D, Schneidewind A, Fadda L, Kadie CM, Carlson JM, et al. HIV-1 adaptation to NK-cell-mediated immune pressure. Nature (2011) 476:96-100. doi:10.1038/nature10237.
162. Fadda L, Körner C, Kumar S, van Teijlingen NH, Piechocka-Trocha A, Carrington M, et al. HLA-Cw*0102-restricted HIV-1 p24 epitope variants can modulate the binding of the inhibitory KIR2DL2 receptor and primary NK cell function. PLoS Pathog (2012) 8:e1002805. doi:10.1371/journal.ppat.1002805.
163. Amadei B, Urbani S, Cazaly A, Fisicaro P, Zerbini A, Ahmed P, et al. Activation of natural killer cells during acute infection with hepatitis C virus. Gastroenterology (2010) 138:1536-45. doi:10.1053/j.gastro.2010.01.006.
164. Khakoo SI. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science (2004) 305:872-4. doi:10.1126/science.1097670.
165. Romero V, Azocar J, Zúñiga J, Clavijo OP, Terreros D, Gu X, et al. Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in hepatitis C virus infection outcome. Mol Immunol (2008) 45:2429-36. doi:10.1016/j.molimm.2008.01.002.
166. Knapp S, Warshow U, Hegazy D, Brackenbury L, Guha IN, Fowell A, et al. Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus. Hepatology (2010) 51:1168-75. doi:10.1002/hep.23477.
167. Ahlenstiel G, Martin MP, Gao X, Carrington M, Rehermann B. Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses. J Clin Invest (2008) 118:1017-26. doi:10.1172/JCI32400.
168. La D, Czarnecki C, El-Gabalawy H, Kumar A, Meyers AF, Bastien N, et al. Enrichment of variations in KIR3DL1/S1 and KIR2DL2/L3 among H1N1/09 ICU patients: an exploratory study. PLoS One (2011) 6:e29200. doi:10.1371/journal.pone.0029200.